|
ZNF75A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.14749987289997E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
4.35762537165374E-13 |
| Stage1-vs-Stage2 |
9.186800E-01 |
| Stage1-vs-Stage3 |
4.660000E-03 |
| Stage1-vs-Stage4 |
2.580200E-02 |
| Stage2-vs-Stage3 |
4.680400E-02 |
| Stage2-vs-Stage4 |
8.169800E-02 |
| Stage3-vs-Stage4 |
9.221400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.61930000000632E-06 |
| Normal-vs-Asian |
7.28230031832311E-10 |
| Caucasian-vs-AfricanAmerican |
5.942800E-01 |
| Caucasian-vs-Asian |
7.525700E-02 |
| AfricanAmerican-vs-Asian |
4.778400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.39808173319034E-13 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.534060E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
1.13819999980613E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.964990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.081150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.042400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.492200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.767800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.994800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.77249999625084E-08 |
| Classical-VS-Follicular |
8.637700E-02 |
| Classical-VS-Other |
3.121800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
5.1416000013127E-08 |
| Tall-VS-Other |
5.664200E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.611000E-01 |
| Follicular-VS-Normal |
3.91849996894678E-09 |
| Other-VS-Normal |
2.154600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.28499988427677E-10 |
| N0-vs-N1 |
4.987600E-01 |
|
|
